Direct and Indirect Effect of TNFα and IFNγ Toward Apoptosis in Breast Cancer Cells
Abstract
Background: Breast cancer (BC) is the leading cause of death cancer in women. Cancer therapies using TNFα and IFNγ have been recently developed by direct effects and activation of immune responses. This study was performed to evaluate the effects of TNFα and IFNγ directly, and TNFα and IFNγ secreted by Conditioned Medium-human Wharton’s Jelly Mesenchymal Stem Cells (CM-hWJMSCs) toward apoptosis of BC cells (MCF7).
Materials and Methods: BC cells were induced by TNFα and IFNγ in 175 and 350ng/mL, respectively. CM-hWJMSCs were produced by co-culture hWJMSCs and NK cells that secreted TNFα, IFNγ, perforin (Prf1), granzyme B (GzmB) for treating BC cells. The BC cells were treated with CM-hWJMSCs in 50%. The expression of apoptotic genes Bax, p53, and the antiapoptotic gene Bcl-2 were determined using RT-PCR.
Results: TNFα and IFNγ at concentration of 350 ng/mL induced higher Bax expression compared to 175 ng/mL. TNFα and IFNγ 350 ng/mL, 175 ng/mL induced p53 expression, whilst TNFα and IFNγ at 350 ng/mL decreased Bcl-2 expression. Perf1, GzmB, TNFα and IFNγ-containing CM-hWJMSCs induced significantly apoptosis percentage, induced Bax expression, but did not effect p53, Bcl-2 expression.
Conclusion: TNFα and IFNγ directly induce Bax, p53, decrease Bcl-2 gene expression. The Prf1, GzmB, TNFα, IFNγ-containing CM-hWJMSCs induce apoptosis and Bax expression.
Keywords: breast cancer, Wharton’s Jelly mesenchymal stem cells, TNFα, IFNγ
Full Text:
PDFReferences
Muti P. The Role of Endogenous Hormones in the Etiology and Prevention of Breast Cancer: The Epidemiological Evidence. In: Senn HJ, Morant R, editors. Tumor Prevention and Genetics III. Recent Results in Cancer Research, Vol 166. Berlin: Springer, 2005. p. 245-56, CrossRef.
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global Cancer Statistics, 2012. CA Cancer J Clin. 2015; 65(2): 87-108, CrossRef.
Tao Z, Shi A, Lu C, Song T, Zhang Z, Zhao J. Breast Cancer: Epidemiology and Etiology. Cell Biochem Biophys. 2015; 72(2): 333-8, CrossRef.
Kimman M, Norman R, Jan S, Kingston D, Woodward M. The Burden of Cancer in Member Countries of the Association of Southeast Asian Nations (ASEAN). Asian Pac J Cancer Prev. 2012; 13(2): 411-21, CrossRef.
Yu LY, Tang J, CongMin Z, WenJing Z, Han Y, MuPeng L. New Immunotherapy Strategies in Breast Cancer. Int J Environ Res Public Health. 2017; 14(1): 68, CrossRef.
Yang ZS, Tang XJ, Guo XR, Zou DD, Sn XY, Feng JB. Cancer Cell-Oriented Migration of Mesenchymal Stem Cells Engineered with an Anticancer Gene (PTEN): An Imaging Demonstration. Onco Targets Ther. 2014; 7: 441-6, CrossRef.
Joyce JA, Pollard JW. Microenvironmental Regulation of Metastasis. Nat Rev Cancer. 2009; 9(4): 239-52, CrossRef.
Kute TE, Savage L, Stehle JR, Kim-Shapiro JW, Blanks MJ, Wood J, et al. Breast Tumor Cells Isolated from In Vitro Resistance to Trastuzumab Remain Sensitive to Trastuzumab Anti-Tumor Effects In Vivo and to ADCC Killing. Cancer Immunol Immunother. 2009; 58(11): 1887-96, CrossRef.
Smyth MJ, Dunn GP, Schreiber RD. Cancer Immunosurveillance and Immunoediting: The Roles of Immunity in Suppressing Tumor Development and Shaping Tumor Immunogenicity. Adv Immunol. 2006; 90: 1-50, CrossRef.
Dewan MZ, Takada M, Terunuma H, Deng X, Ahmed S, Yamamoto N, et al. Natural Killer Activity of Peripheralblood Mononuclear Cells in Breast Cancer Patients. Biomed Pharmacother. 2009; 63: 703-6, CrossRef.
Caras I, Grigorescu A, Stavaru C, Radu DL, Mogos I, Szegli G. Evidence for Immune Defects in Breast and Lung Cancer Patients. Cancer Immunol Immunother. 2004; 53(12): 1146-52, CrossRef.
Levy EM, Roberti MP, Mordoh J. Natural Killer Cells in Human Cancer: from Biological Functions to Clinical Applications. J Biomed Biotechnology. 2011; 2011: 1-11, CrossRef.
Hwang YJ, Kim J, Park DS. Study on The Immunomodulation Effect of Isodon japonicus Extract via Splenocyte Function and NK Anti-Tumor Activity. Int J Mol Sci. 2012; 13: 4880-88, CrossRef.
Esendagli G, Bruderek K, Goldmann T, Busche A, Branscheid D, Vollmer E. Malignant and Non-malignant Lung Tissue Areas are Differentially Populated by Natural Killer Cells and Regulatory T Cells in Non-small Cell Lung Cancer. Lung Cancer. 2008; 59(1): 32-40, CrossRef.
Albertsson PA, Basse PH, Hokland M, Goldfarb RH, Nagelkerke JF, Nannmark U. NK Cells and The Tumour Microenvironment: Implications for NK-cell Function and Anti-tumour Activity. Trends Immunolog. 2003; 24(11): 603-9, CrossRef.
James AM, Cohen AD, Campbell KS. Combination Immune Therapies to Enhance Anti-tumor Responses by NK cells. Frontiers Immunolog. 2013; 4(481): 1-12, CrossRef.
Carson WE, Fehniger TA, Haldar S, Eckhert K, Lindemann MJ, Lai CF. A Potential Role for Interleukin-15 in the Regulation of Human Natural Killer Cell Survival. J Clin Invest. 1997; 99(5): 937-43, CrossRef.
Zwirner NW, Domaica CI. Cytokine Regulation of Natural Killer Cell Effector Functions. Biofactors. 2010; 36(4): 274-28, CrossRef.
Domaica CI, Fuertes MB, Uriarte I, Girart MV, Sardañons J, Comas DI, et al. Human Natural Killer Cell Maturation Defect Supports in vivo CD56 Bright to CD56 Dim Lineage Development. PLoS One. 2012; 7(12): e51677, CrossRef.
Shah K. Mesenchymal Stem Cells Engineered for Cancer Therapy. Adv Drug Deliv Rev. 2012; 64(8): 739-48, CrossRef.
Menon LG, Picinich S, Koneru R. Differential Gene Expression Associated with Migration of Mesenchymal Stem Cells to Conditioned Medium from Tumor Cells or Bone Marrow Cells. Stem Cells. 2007; 25(2): 520-8, CrossRef.
Yu X, Boxing S, Peng G, Zicheng W, Sen L, Bingwei H, et al. Human Adipose Derived Stem Cells Induced Cell Apoptosis and S Phase Arrest in Bladder Tumor. Stem Cell Int. 2015; 2015: 1-12, CrossRef.
Ding D, Chang Y, Shyu W, Lin S. Human Umbilical Cord Mesenchymal Stem Cells: A New Era for Stem Cell Therapy. Cell Transplant. 2015; 24(3): 339-47, CrossRef.
Widowati W, Wijaya L, Murti H, Widyastuti H, Agustina D, Laksmitawati DR. Conditioned Medium from Normoxia (WJMSCsnorCM) and Hypoxia-treated WJMSCs (WJMSCs-hypoCM) in Inhibiting Cancer Cell Proliferation. Biomarkers Gen Med. 2015; 7(1): 8-17, CrossRef.
Loebinger MR, Janes SM. Stem Cells as Vectors for Antitumour Therapy. Thorax. 2010; 65(4): 362-9, CrossRef.
Sun B, Roh KH, Park JR. Therapeutic Potential of Mesenchymal Stromal Cells in A Mouse Breast Cancer Metastasis Model. Cytother. 2009; 11(3): 289-98, CrossRef.
Ghavami S, Eshraghi M, Kadkhoda K, Mutawe MM, Maddika S, Bay GH, et al. Role of BNIP3 in TNF-induced Cell Death — TNF Upregulates BNIP3 Expression. Biochimica et Biophysica Acta. 2009; 1793(3): 546-60, CrossRef.
Chawla-Sarkar M, Leaman DW, Borden EC. Preferential Induction of Apoptosis by Interferon (IFN)-beta Compared with IFN-alpha2: Correlation with TRAIL/Apo2L Induction in Melanoma Cell Lines. Clin Cancer Res. 2001; 7(6): 1821-31, PMID.
Ikeda H, Old LJ, Schreiber RD. The Roles of IFN γ in Protection Against Tumor Development and Cancer Immunoediting. Cytokine Growth Factor Rev. 2002; 13(2): 95-109, CrossRef.
Widowati W, Murti H, Jasaputra DK, Sumitro SB, Widodo MA, Fauziah N, et al. Selective Cytotoxic Potential of IFN-γ and TNF-α on Breast Cancer Cell Lines (T47D and MCF7). Asian J Cell Biol. 2016; 11(1): 1-12, CrossRef.
Lu YR, Yuan Y, Wang XJ, Wei LL, Chen YN, Cong C, et al. The Growth Inhibitory Effect of Mesenchymal Stem Cells on Tumor Cells in vitro and in vivo. Cancer Biol Ther. 2008; 7(2): 245-51, CrossRef.
Jewett A, Tseng HC. Tumor Induced Inactivation of Natural Killer Cell Cytotoxic Function; Implication in Growth, Expansion and Differentiation of Cancer Stem Cells. J Cancer. 2011; 2: 443-57, CrossRef.
Parihar R, Dierksheide J, Hu Y, Carson WE. IL-12 Enhances the Natural Killer Cell Cytokine Response to Ab-coated Tumor Cells. J Clin Invest. 2002; 110(7): 983-92, CrossRef.
Widowati W, Mozef T, Risdian C, Yelliantty Y. Anticancer and Free Radical Scavenging Potency of Catharanthus roseus, Dendrophthoe petandra, Piper betle and Curcuma mangga Extracts in Breast Cancer Cell Lines. Oxid Antioxid Med Sci. 2013; 2(2): 137-42, CrossRef.
Widowati W, Wijaya L, Wargasetia TL, Bachtiar I, Yelliantty Y, Laksmitawati DR. Antioxidant, Anticancer, and Apoptosis-inducing Effects of Piper extracts in HeLa Cells. J Exp Integr Med. 2013; 3(3): 225-230, CrossRef.
Kalaszczynska I, Ferdyn K. Wharton’s Jelly derived Mesenchymal Stem Cells: Future of Regenerative Medicine? Recent Findings and Clinical Significance. Biomed Res Int. 2015; 2015: 1-11, CrossRef.
Hidayat M, Prahastuti S, Fauziah N, Maesaroh M, Balqis B, Widowati W. Modulation of Adipogenesis-related Gene Expression by Ethanol Extracts of Detam 1 Soybean and Jati belanda Leaf in 3T3-L1 Cells. Bangladesh J Pharmacol. 2016; 11: 697-702, CrossRef.
Aggarwal S, Pittenger MF. Human Mesenchymal Stem Cells Modulate Allogeneic Immune Cell Responses. Blood. 2005; 105(4): 1815-22, CrossRef.
Sotiropoulou PA, Perez SA, Salagianni M, Baxevanis CN, Papamichail M. Characterization of the Optimal Culture Conditions for Clinical Scale Production of Human Mesenchymal Stem Cells. Stem Cells. 2006; 24(2): 462-71, CrossRef.
Krampera M, Cosmi L, Angeli R, Pasini A, Liotta F, Andreini A, et al. Role for Interferon-gamma in the Immunomodulatory Activity of Human Bone Marrow Mesenchymal Stem Cells. Stem Cells. 2006; 24(2): 386-98, CrossRef.
Kovach TK, Dighe AS, Lobo PI, Cui Q. Interactions between MSCs and Immune Cells: Implications for Bone Healing. J Immunol Res. 2015; 2015: 752510, CrossRef.
Wang Y, Wang X, Zhao H, Liang B, Du Q. Clusterin Confers Resistance to TNF-alpha-induced Apoptosis in Breast Cancer Cells through NF-kappaB Activation and Bcl-2 Overexpression. J Chemother. 2012; 24(6): 348-57, CrossRef.
Cheng M, Chen Y, Xiao W, Sun R, Tian Z. NK Cell-based Immunotherapy for Malignant Diseases. Cell Mol Immunol. 2013; 10(3): 230-52, CrossRef.
Reefman E, Kay JG, Wood SM, Offenhäuser C, Brown DL, Roy S, et al. Cytokine Secretion is Distinct from Secretion of Cytotoxic Granules in NK Cells. J Immunol. 2010; 184(9): 4852-62, CrossRef.
Kelly JM, Darcy PK, Markby JL, Godfrey DI, Takeda K, Yagita H. Induction of Tumor-specific T Cell Memory by NK Cell-mediated Tumor Rejection. Nat Immunol. 2002; 3(1): 83-90, CrossRef.
Maestroni GJ, Hertens E, Galli P. Factors from Nonmacrophage Bone Marrow Stromal Cells Inhibit Lewis Lung Carcinoma and B16 Melanoma Growth in Mice. Cell Mol Life Sci. 1999; 55(4): 663-7, CrossRef.
Nakamura K, Ito Y, Kawano Y, Kurozumi K, Kobune M, Tsuda H. Antitumor Effect of Genetically Engineered Mesenchymal Stem Cells in a Rat Glioma Model. Gene Ther. 2004; 11(14): 1155-64, CrossRef.
Qiao C, Xu W, Zhu W, Hu J, Qian H, Yin Q. Human Mesenchymal Stem Cells Isolated from the Umbilical Cord. Cell Biol Int. 2008; 32(1): 8-15, CrossRef.
Qiao L, Xu Z, Zhao T, Zhao Z, Shi M, Zhao RC. Suppression of Tumorigenesis by Human mesenchymal Stem Cells in a Hepatoma Model. Cell Res. 2008; 18(4): 500-7, CrossRef.
Feng DQ, Zhou Y, Ling B. Effects of The Conditioned Medium of Mesenchymal Stem Cells on Mouse Oocyte Activation and Development. Braz J Med Biol Res. 2009; 42(6): 506-14, CrossRef.
Mintz PJ, Huang KW, Reebye V. Exploiting Human CD34+ Stem Cell–conditioned Medium for Tissue Repair. Mol Ther. 2013; 22(1): 149-59, CrossRef.
Lakshmikanth T, Johansson MH. Current Perspectives on Immunomodulation of NK Cells in Melanoma. n.p; INTECH Open Access Publisher; 2011, article.
Mamessier E, Sylvain A, Thibult ML, Houvenaeghel G, Jacquemier J, Castellano R, et al. Human Breast Cancer Cells Enhance Self Tolerance by Promoting Evasion from NK Cell Antitumor Immunity. J Clin Inves. 2011; 121(9): 3609-22, CrossRef.
Wang LF, Wang F, Li JT, Wen WH, Zhao J, Jia LT, et al. Ectopically Expressed Perforin-1 is Proapoptotic in Tumor Cell Lines by Increasing Caspase-3 Activity and The Nuclear Translocation of Cytochrome c. PLoS ONE. 2012; 7(7): 1-11, CrossRef.
Jiang MC, Luo SF, Li LT, Lin CC, Du SY, Lin CY, et al. Synergic CSE1L/CAS, TNFR-1, and p53 Apoptotic Pathways in Combined Interferon-gamma/Adriamycin-induced Apoptosis of Hep G2 Hepatoma Cells. J Exp Clin Cancer Res. 2007; 26(1): 91-9, PMID.
Vanhaesebroeck B, Reed JC, De Valck D, Grooten J, Miyashita T, Tanaka S, et al. Effect of bcl-2 proto-oncogene Expression on Cellular Sensitivity to Tumor Necrosis Factor-mediated Cytotoxicity. Oncogene. 1993; 8(4): 1075-81, PMID.
Jaattela M, Benedict M, Tewari M, Shayman JA, Dixit VM. Bcl-x and Bcl-2 Inhibit TNF and Fas-induced Apoptosis and Activation of Phospholipase A2 in Breast Carcinoma Cells. Oncogene. 1995; 10(12): 2297-305, PMID.
Rozen F, Zhang J, Pollak M. Antiproliferative Action of Tumor Necrosis Factor-α on MCF-7 Breast Cancer Cells is Associated with Increased Insulin-like Growth Factor Binding Protein-3 Accumulation. Int J Oncol. 1998; 13(4): 865-9, CrossRef.
Schedlich LJ, Young TY, Firth SM, Baxter RC. Insulin-like Growth Factorbinding Protein (IGFBP)-3 and IGFBP-5 Share a Common Nuclear Transport Pathway in T47D Human Breast Carcinoma Cells. J Biol Chem. 1998; 273(29): 18347-52, CrossRef.
Schedlich LJ, Le Page SL, Firth S, Briggs LJ, Jans DA, Baxter RC. Nuclear Import of Insulin-like Growth Factor Binding Protein-3 (IGFBP-3) and IGFBP-5 is Mediated by the Importin Subunit. J Biol Chem. 2000; 275(31): 23462-70, CrossRef.
Butt AJ, Fraley KA, Firth SM, Baxter RC. Insulin-like Growth Factor Binding Protein-3-induced Growth Inhibition and Apoptosis Do Not Require Cell-surface Binding and Nuclear Translocation in Human Breast Cancer Cells. Endocrinolog. 2002; 143(7): 2693-9, CrossRef.
Butt AJ, Dickson KA, McDougall F, Baxter RC. Insulin-like Growth Factor Binding Protein-5 Inhibits the Growth of Human Breast Cancer Cells in vitro and in vivo. J Biol Chem. 2003; 278(32): 29676-85, CrossRef.
Chau BN, Chen TT, Wan YY, DeGregori J, Wang J. Tumor Necrosis Factor Alpha-induced Apoptosis Requires p73 and c-ABL Activation Downstream of RB Degradation. Mol Cell Biol. 2004; 24(1): 4438-47, PMID.
Detjen KM, Farwig K, Welzel M, Wiedenmann B, Rosewicz S. Interferon ã Inhibits Growth of Human Pancreatic Carcinoma Cells via Caspase-1 Dependent Induction of Apoptosis. Gut. 2001; 49(2): 251-62, CrossRef.
Pawitan JA. Prospect of Stem Cell Conditioned Medium in Regenerative Medicine. Biomed Res Int. 2014; 2014: 1-14, CrossRef.
Yang ZS, Tang XJ, Guo XR, Zou DD, Sn XY, Feng JB. Cancer Cell-Oriented Migration of Mesenchymal Stem Cells Engineered with an Anticancer Gene (PTEN): An Imaging Demonstration. Onco Targets Ther. 2014; 7: 441-6, CrossRef.
Domaica CI, Fuertes MB, Uriarte I. Human Natural Killer Cell Maturation Defect Supports in vivo CD56 Bright to CD56 Dim Lineage Development. PLoS ONE. 2012; 7(12): 1-12,
Huntington ND, Legrand N, Alves NL. IL-15 Trans-presentation Promotes Human NK Cell Development and Differentiation in vivo. J Exp Med. 2009; 206(1): 25-34, CrossRef.
Yu TK, Caudal EG, Smid C. Ay IL-2 Activation of NK Cells: Involvement of MKK1/2/ERK but Not p38 Kinase Pathway. J Immunol. 2000; 164(12): 6244-51, CrossRef.
Thomas H, Jäger H, Mauel K. Interaction with Mesenchymal Stem Cells Provokes Natural Killer Cells for Enhanced IL-12/IL-18-induced Interferon-Gamma Secretion. Mediators Inflam. 2014; 2014: 1-11, CrossRef.
Bhat R, Watzl C. Serial Killing of Tumor Cells by Human Natural Killer Cells – Enhancement by Therapeutic Antibodies. PLoS ONE. 2007; 2(3): 1-7, CrossRef.
Lieberman J. The ABCs of Granule-mediated Cytotoxicity: New Weapons in the Arsenal. Nat Rev Immunol. 2003; 3(5): 361-70, CrossRef.
Waldmann TA, Dubois S, Tagaya Y. Contrasting Roles of IL-2 and IL-15 in the Life and Death of Lymphocytes: Implications for Immunotherapy. Immunity. 2001; 14(2): 105-10, CrossRef.
Gluck WL, Hurst D, Yuen A, Levine AM, Dayton MA. Phase I Studies of Interleukin (IL)-2 and Rituximab in B-cell Nonhodgkin’s Lymphoma: IL-2 Mediated Natural Killer Cell Expansion Correlations with Clinical Response. Clin Cancer Res. 2004; 10(7): 2253-64, CrossRef.
Waldmann TA. The Biology of Interleukin-2 and Interleukin-15: Implications for Cancer Therapy and Vaccine Design. Nat Rev Immunol. 2006; 6(8): 595-601, CrossRef.
Brodbeck T, Nehmann N, Bethge A, Wedemann G, Schumacher U. Perforin-dependent Direct Cytotoxicity in Natural Killer Cells Induces Considerable Knockdown of Spontaneous Lung Metastases and Computer Modelling-Proven Tumor Cell Dormancy in A HT29 Human Colon Cancer Xenograft Mouse Model. Molecular Cancer. 2014; 13(244): 1-11, CrossRef.
Rousalova I, Krepela E. Granzyme B-induced Apoptosis in Cancer Cells and Its Regulation. Int J Oncolog. 2010; 37(6): 1361-78, CrossRef.
Catalán E, Jaime-Sánchez P, Aguiló N. Mouse Cytotoxic T Cell-Derived Granzyme B Activates the Mitochondrial Cell Death Pathway in a Bim-dependent Fashion. J Biol Chem. 2015; 290(11): 6868-77, CrossRef.
Meslin F, Thiery J, Richon C, Jalil A, Chouaib S. Granzyme B-induced Cell Death Involves Induction of p53 Tumor Suppressor Gene and Its Activation in Tumor Target Cells. J Biol Chem. 2007; 282(45): 32991-9, CrossRef.
DOI: https://doi.org/10.21705/mcbs.v2i2.21
Copyright (c) 2018 Cell and BioPharmaceutical Institute
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Indexed by:
Cell and BioPharmaceutical Institute
